Latest filings (excl ownership)
10-K
2023 FY
Annual report
12 Mar 24
8-K
CORMEDIX INC. REPORTS fourth QUARTER and full year 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
12 Mar 24
8-K
CORMEDIX INC. announces commercial AND REiMBURSEMENT updates
30 Jan 24
8-K
Departure of Directors or Certain Officers
15 Dec 23
8-K
CORMEDIX INC. ANNOUNCES FDA APProval of Defencath® To reduce
16 Nov 23
8-K
Cormedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
30 Oct 23
ARS
2022 FY
Annual report to shareholders
13 Sep 23
DEFA14A
Additional proxy soliciting materials
13 Sep 23
DEF 14A
Definitive proxy
13 Sep 23
8-K
Departure of Directors or Certain Officers
17 Aug 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2023 Financial Results and Provides Business Update
8 Aug 23
8-K
Cormedix Inc. Announces Proposed Public Offering of Common Stock and Pre-funded Warrants
30 Jun 23
424B5
Prospectus supplement for primary offering
30 Jun 23
424B5
Prospectus supplement for primary offering
28 Jun 23
8-K
Cormedix Inc. Announces Fda Acceptance of Resubmission of New Drug Application for Defencath
21 Jun 23
8-K
CorMedix Inc. ANNOUNCES RESUBMISSION Of New drug application for defencath
16 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
15 May 23
8-K
Cormedix Inc. Announces Regulatory, Manufacturing and
26 Apr 23
8-K
Cormedix Inc. Announces Appointment of Robert a. Stewart to Its Board of Directors
17 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
CORMEDIX INC. REPORTS fourth QUARTER and full year 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
30 Mar 23
8-K
Cormedix Inc. Announces Regulatory and Manufacturing Updates
3 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Cormedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
10 Nov 22
S-8
Registration of securities for employees
26 Oct 22
8-K
Changes in Registrant's Certifying Accountant
21 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
17 Oct 22
DEFA14A
Additional proxy soliciting materials
30 Aug 22
DEF 14A
Definitive proxy
30 Aug 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
8-K
CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2022 Financial Results and Provides Business Update
11 Aug 22
8-K
Cormedix Inc. Announces Regulatory and Manufacturing Updates
9 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
8-K
CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
12 May 22
10-K
2021 FY
Annual report
29 Mar 22
8-K
CORMEDIX INC. REPORTS fourth QUARTER and full year 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
29 Mar 22
Latest ownership filings
4
Steven W Lefkowitz
20 Mar 24
4
Robert A Stewart
20 Mar 24
4
Myron Kaplan
20 Mar 24
4
Janet Dillione
20 Mar 24
4
ALAN W DUNTON
20 Mar 24
4
Gregory Scott Duncan
20 Mar 24
4
Joseph Todisco
14 Mar 24
SC 13G/A
NOMURA HOLDINGS INC
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G
BlackRock Inc.
29 Jan 24
4/A
Elizabeth Masson-Hurlburt
18 Jan 24
4
Elizabeth Masson-Hurlburt
17 Jan 24
4
Matthew T David
17 Jan 24
4
Erin Mistry
17 Jan 24
4
Joseph Todisco
17 Jan 24
4
ALAN W DUNTON
18 Dec 23
4
Kaufman Beth Zelnick
14 Dec 23
3
Kaufman Beth Zelnick
14 Dec 23
4
Erin Mistry
21 Nov 23
4
Steven W Lefkowitz
17 Nov 23
4
Joseph Todisco
8 Sep 23
4
Myron Kaplan
19 May 23
4/A
Paulo F Costa
18 May 23
4/A
ALAN W DUNTON
18 May 23
4/A
Robert A Stewart
18 May 23
4/A
Joseph Todisco
18 May 23
4
Paulo F Costa
17 May 23
4
ALAN W DUNTON
17 May 23
4
Robert A Stewart
17 May 23
4
Joseph Todisco
17 May 23
4
Joseph Todisco
12 May 23
4
Robert A Stewart
17 Apr 23
3
Robert A Stewart
17 Apr 23
SC 13G/A
NOMURA HOLDINGS INC
14 Feb 23
4
Erin Mistry
20 Jan 23
3
Erin Mistry
20 Jan 23
4
Joseph Todisco
18 Jan 23
4
Phoebe Mounts
18 Jan 23
4
Steven W Lefkowitz
18 Jan 23
4
Janet Dillione
18 Jan 23